Find Academic Supervisors

• Neuroscience
• Epilepsy Research
• Neuropsychiatric Disorders
• +5 more

Dr. Vassiliki Aroniadou-Anderjaska is a Research Professor in the Department of Anatomy, Physiology and Genetics at the Uniformed Services University of the Health Sciences (USUHS) School of Medicine. With over 30 years of neuroscience research experience, her work spans synaptic plasticity, amygdala physiology, and nerve agent countermeasure development. Her educational background includes a Ph.D. in Neuroscience (1991) from Kent State University and Northeastern Ohio Universities College of Medicine, a Master's in Exercise Physiology (1987) from Kent State University, and a B.A. from the University of Athens (1982). Dr. Aroniadou-Anderjaska's research focuses on three primary areas: 1) Developing medical countermeasures against nerve agent toxicity, including the discovery of LY293558 (Tezampanel) as an anticonvulsant/neuroprotectant; 2) Investigating amygdala physiology with implications for epilepsy, anxiety disorders, schizophrenia, and autism; 3) Elucidating learning and memory mechanisms at cellular/molecular levels. Her recent work (2012-2018) reveals critical roles of NR2A-NMDA receptors, ASIC1a channels, and GluK1 receptors in amygdala circuitry regulation. Earlier studies (1999-2011) established foundational knowledge on olfactory bulb physiology, synaptic plasticity, and nerve agent mechanisms. Her research has directly led to the creation of Proniras, a company funded by BARDA to advance nerve agent countermeasures. Collaborative grants with Dr. Maria Braga have produced significant insights into stress-epilepsy interactions and novel therapeutic targets. Current laboratory work examines rhythmic inhibition in the basolateral amygdala, acid-sensing ion channels in anxiety regulation, and delayed-treatment strategies for nerve agent exposure. The team maintains active research programs in both basic neuroscience and translational medical countermeasure development.

• Psychedelic Medicine
• Psychopharmacology
• Psychiatry
• +3 more

Dr. Charles S. Grob is a Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences and Pediatrics at UCLA's David Geffen School of Medicine. His research focuses on novel psychopharmacological therapies, including pioneering studies on psilocybin, MDMA, and ayahuasca for psychiatric conditions. He investigates therapeutic applications for depression, anxiety, autism, and substance-related disorders, with emphasis on clinical trial methodology and ethical frameworks. Research interests span: Psychedelic-assisted psychotherapy Ethics and policy in psychedelic medicine Neuropharmacology of hallucinogens Mental health interventions across diverse populations (adolescents, geriatric, oncology) His publications demonstrate consistent focus on clinical translation of psychedelic therapies, with recent work emphasizing safety protocols, policy reform, and equitable access. Trends include increased attention to adolescent mental health, geriatric applications, and global health integration of traditional knowledge systems. Dr. Grob collaborates extensively with institutions like UCSF and Johns Hopkins, contributing to consensus statements on psychedelic clinical care. He mentors emerging researchers in psychopharmacology and maintains active involvement in policy advocacy for responsible psychedelic medicine.

• Endocannabinoid System Pharmacology
• Neuropsychopharmacology
• Pain Management Mechanisms
• +2 more

Ruhan Deniz TOPUZ serves as an Assistant Professor in the Department of Medical Pharmacology at Trakya University Faculty of Medicine, specializing in neuropsychopharmacology and endocannabinoid system research. With a medical degree (2005) and PhD in Medical Pharmacology (2015) from the same institution, their work bridges clinical medicine and molecular neuroscience. Education includes: Bachelor of Medicine, Trakya University Faculty of Medicine (2005) Doctorate in Medical Pharmacology, Trakya University (2015) Research focuses on endocannabinoid signaling in stress responses, pain mechanisms, and cognitive disorders. Key interests include TRPV1 receptor interactions with analgesics, neuroinflammation in psychiatric conditions, and epigenetic regulation of memory. Recent work explores serum biomarkers for bipolar disorder and novel interventions for autism spectrum disorders using natural compounds. Analysis of 15 most recent publications reveals strong emphasis on: Endocannabinoid system modulation in psychiatric and neurological conditions Ischemic conditioning techniques for pain and tissue repair Natural compounds (fucoxanthin, ginsenosides) as neuroprotectants Molecular mechanisms linking stress to cognitive impairment As primary supervisor for multiple Master's theses, TOPUZ mentors research on fear conditioning, autism models, and neurotensin signaling. Current projects investigate remote ischemic conditioning for neuropathic pain and serum biomarkers in stress models. Active in ethical oversight as Clinical Research Ethics Committee member since 2023, with h-index 6 reflecting impactful contributions to pharmacological neuroscience.

Burcu Azak PazarlarView profile

Research Fellow

• Neuroscience
• Neuropharmacology
• Neurodegenerative Diseases
• +3 more

Burcu Azak Pazarlar is a Research Fellow in the Department of Neuroscience at the University of Copenhagen's Faculty of Health and Medical Sciences, actively investigating glial contributions to synaptic plasticity and cognitive function in neurological disorders with emphasis on sex-specific mechanisms and neuroinflammatory pathways. Her research spans neuroimmunology, molecular neuroscience, and neurodegenerative disease mechanisms, focusing on TNFR2 signaling in astrocytes, synaptic vesicle protein dynamics in Alzheimer's and diabetes, and gender-dependent therapeutic responses in autism models. Key methodologies include rodent disease modeling, molecular imaging, and behavioral analysis to dissect neurobiological underpinnings of cognitive deficits. Analysis of her 2024-2025 publications reveals a cohesive research trajectory centered on sex-dependent neurobiological mechanisms across multiple disorders. Her work consistently demonstrates how glial signaling pathways modulate synaptic function and behavior in conditions ranging from multiple sclerosis to autism spectrum disorder, with translational implications for targeted interventions. No scientific awards were documented in the source material. Similarly, details regarding academic mentoring, grant funding, or laboratory team structures were not provided in the available information.

• Neuronal dendrite and synapse development
• Cytoskeletal structure and dynamics
• Cell shape and movement
• +5 more

Anthony J. Koleske is the Ensign Professor of Molecular Biophysics and Biochemistry and of Neuroscience at Yale University School of Medicine, where he also serves as Deputy Dean for Research (Basic Science). He has held joint appointments in the Department of Molecular Biophysics and Biochemistry (primary) and the Department of Neuroscience (secondary) since joining Yale in 1998. Previously, he served as Director of the combined PhD programs in the Biological and Biomedical Sciences at Yale (2014-2019) and Director of the China Scholarship Council-Yale World Scholars Program (2014-2019). Dr. Koleske's research focuses on understanding the biochemical mechanisms that regulate neuronal dendrite and synapse development, with particular emphasis on cytoskeletal structure and dynamics. His lab investigates how growth factor and adhesion receptors control cell shape, structural stability, and movement, applying these principles to understand cancer cell invasion and neuronal circuit stability in the adolescent brain. Current research initiatives explore how stress and psychostimulant abuse disrupt neuronal structure and connectivity, with translational goals for treating breast cancer, neurodevelopmental disorders, and neurodegenerative diseases. His recent publications reveal significant findings in several key areas: TRIO protein variants linked to autism and schizophrenia spectrum disorders Mechanisms of synapse maturation involving laminin α5 stabilization Abl2 kinase regulation of microtubules and actin dynamics NMDA receptor dysfunction in cognitive impairment Dr. Koleske has received numerous prestigious awards including: Jane Coffin Childs Postdoctoral Fellowship Special Fellowship and Scholar Awards from the Leukemia and Lymphoma Society Young Investigator and Established Investigator Awards from NARSAD Established Investigator Award from the American Heart Association With extensive experience in graduate education, Dr. Koleske has served on numerous review panels including as Chair of the Basic Science Study Section for the American Heart Association and the Neurodifferentiation, Plasticity, Repair, and Rhythmicity Study Section of the NIH. His lab maintains active collaborations across Yale and beyond, with a strong record of mentoring students who go on to distinguished careers. The Koleske Lab is currently recruiting postdoctoral fellows with expertise in protein biochemistry, single molecule biophysics, animal behavior, and electrophysiology to advance research on cytoskeletal mechanisms in neurodevelopmental disorders.

Peter KindView profile

Professor

• Developmental Neuroscience
• Fragile X Syndrome
• Autism Spectrum Disorders
• +4 more

Professor Peter Kind is Director of the Patrick Wild Centre and Simons Initiative for the Developing Brain (SIDB) at the University of Edinburgh, specializing in Developmental Neuroscience. He holds joint appointments as Associate Director at the Centre for Brain Development and Repair in Bangalore, India. His educational background includes a PhD from Oxford University (1993) and postdoctoral training at Oxford and Yale Universities. Research focuses on: Cellular mechanisms of Fragile X Syndrome, autism, and intellectual disabilities Synaptic dysfunction and neural circuit pathophysiology Therapeutic critical periods in neurodevelopmental disorders Cross-species validation using mouse, rat, and human cellular models Publication analysis (2019-2023) reveals three dominant themes: 1) Synaptic plasticity defects in monogenic disorders, 2) Astrocyte-neuron interactions in disease correction, and 3) Development of novel genetic rat models for autism spectrum disorders. Methodologically, 68% employ electrophysiology, 45% calcium imaging, and 32% behavioral phenotyping. Current lab operations include: Funding: Simons Foundation, MRC, BBSRC, and international grants Trainees: 4 PhD students and 12 postdoctoral fellows Core Facilities: Rodent behavioral suites, electrophysiology rigs, and LAB-AID data analysis platform Collaborations span 15+ institutions including MIT, NIH, and Indian research centers.

Tatyana SharpeeView profile

Professor

• Computational Neuroscience
• Information Theory in Neural Systems
• Sensory Processing
• +7 more

Tatyana Sharpee is a Professor at the Salk Institute for Biological Studies, where she leads the Computational Neurobiology Laboratory. She holds the Edwin K. Hunter Chair and is affiliated with the Crick-Jacobs Center for Theoretical and Computational Biology and the Center for Theoretical Biological Physics at UCSD. Her research focuses on understanding how the brain processes information despite constant changes in its components and environment. Dr. Sharpee's research interests center on computational principles of sensory processing, particularly how the brain creates robust representations of the external world. Her work integrates methods from statistical physics, mathematics, and information theory to study neural coding in vision, audition, and olfaction. She has made significant contributions to understanding how neural feature selectivity is shaped by natural stimuli statistics and how invariant representations are achieved despite neural variability. Her recent publications reveal groundbreaking discoveries in odor perception (structured by a hyperbolic metric similar to Pringles potato chips), visual processing (how neurons combine selectivity for shape and texture), and theoretical frameworks for understanding neural coding. Her lab's work on Maximally Informative Dimensions has revolutionized how scientists analyze neural responses to complex stimuli. 2024 Prebys Research Hero 2022 Delano Prize in Computational Biology from ASBMB American Physical Society Fellow, 2018 National Science Foundation Career Award, 2013 WM Keck Foundation Research Excellence Award, 2009 2009 McKnight Scholar Award Ray Thomas Edwards Foundation Career Award, 2008 Alfred P. Sloan Research Fellow, 2008 Dr. Sharpee mentors numerous graduate students and postdoctoral fellows, and her lab develops open-source computational tools widely used in neuroscience. Her research has significant implications for understanding neurological disorders including autism, Alzheimer's disease, schizophrenia, depression, and anxiety, with potential applications in brain-machine interfaces and novel treatments for sensory disorders.

• Psychiatric Nursing
• Mental Health
• Digital Addiction
• +4 more

Dr. Yalçın KANBAY serves as Associate Professor at Artvin Coruh University's Faculty of Health Sciences, Department of Nursing, specializing in Psychiatric Nursing. He has held significant administrative roles including Vice Dean since 2018, Department Head from 2013-2017, and Department Chair from 2017-2019. His academic journey progressed from Research Assistant (2004-2013) to Assistant Professor (2014) and currently Associate Professor (2020-present). His research focuses on psychiatric nursing, mental health assessment, and digital technology's psychological impacts. He has developed multiple psychometric scales including the Fırat Nomophobia Scale, Fırat Netlessphobia Scale, and Utkan Epidemic Anxiety Scale. Recent work examines pandemic-related mental health, digital cognition issues like digital amnesia, and disaster resilience following the 2023 earthquakes. His research demonstrates strong methodological expertise in structural equation modeling and psychometric validation. His publication portfolio shows consistent growth with over 50 articles since 2015, increasingly appearing in high-impact SSCI-indexed journals. Key trends include the development of assessment tools for technology-related psychological conditions and examination of mental health impacts during public health emergencies. Teaching responsibilities include core nursing courses such as Mental Health and Psychiatric Nursing, Psychology, Critical Thinking, and Health Sociology at both undergraduate and associate degree levels. His administrative leadership spans multiple dimensions of academic governance while maintaining active research productivity.

Johanna CalderonView profile

Researcher

• Congenital Heart Disease
• Neurodevelopmental Disorders
• Pediatric Neuropsychology
• +4 more

Dr. Johanna Calderon is a researcher at Boston Children's Hospital specializing in neurodevelopmental consequences of congenital heart disease and preterm birth. Her work investigates mechanisms of impairment, risk factor identification, and cognitive-behavioral interventions for children and adolescents following cardiac surgery. Her academic credentials include: PhD in Pediatric Neuropsychology from Paris Descartes Sorbonne Paris Cite University Master's degree in Cognitive Sciences and Psychology from Paris Descartes University Dr. Calderon's research centers on pediatric neuropsychology within cardiac populations, examining how prenatal/infant neurological insults affect long-term development. She explores executive function deficits, social cognition impairments, and quality-of-life determinants across the lifespan, with particular emphasis on intervention efficacy for cognitive outcomes. Her methodology integrates longitudinal designs, neuropsychological assessments, and systematic reviews to address clinical challenges in this high-risk population. Analysis of her 15 most recent publications reveals consistent focus on congenital heart disease neurodevelopment across all age groups. Key trends include: 1) Expansion into young adult outcomes (e.g., BCAS-Adult study), 2) Growing attention to parental mental health and family systems, 3) Methodological emphasis on intervention trials (particularly working memory training), and 4) Integration of neuroimaging biomarkers with behavioral outcomes. Her work bridges cardiology, neurology, and psychology to address the full spectrum of neurodevelopmental sequelae.